Increased Sulfiredoxin Expression in Gastric Cancer Cells May Be a Molecular Target of the Anticancer Component Diallyl Trisulfide

Sulfiredoxin (Srx) is a newly discovered antioxidant enzyme playing a role in the catalytic reduction of oxidative modifications. Srx is overexpressed in a variety of cancers. It may promote carcinogenesis as well as tumor progression. In this study, we report for the first time that Srx expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Juan, Si, Ligang, Wang, Genyu, Bai, Zhigang, Li, Wenmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378787/
https://www.ncbi.nlm.nih.gov/pubmed/30863778
http://dx.doi.org/10.1155/2019/4636804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378787/
https://www.ncbi.nlm.nih.gov/pubmed/30863778
http://dx.doi.org/10.1155/2019/4636804

Ejemplares similares